Ligand-targeted mirna delivery for prostate cancer therapy

Ended Project Grant Awarded Last action

Award ID
W81XWH2110181
Recipient
Awarding agency
Obligated
$465,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
West Lafayette, IN 47907, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

Purdue University will use a $465,000 Project Grant award from the Department of the Army Medical Command to support research titled "LIGAND-TARGETED MIRNA DELIVERY FOR PROSTATE CANCER THERAPY" from March 2021 to February 2023. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Specifically, Purdue University researchers will investigate using targeted microRNA delivery as a potential new therapy for prostate cancer. They will develop ligand-targeted nanoparticles to deliver anti-cancer microRNAs and evaluate their therapeutic potential. The research has the potential to lead to new medical solutions for Service Members and the general public.

Quick answers

Who received award W81XWH2110181?

W81XWH2110181 was awarded to Purdue University by Medical Command (Department of the Army) on March 1, 2021.

How much is award W81XWH2110181 worth?

$465,000 has been obligated on W81XWH2110181.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login